Permax
Sunday, June 1st, 2003Permax was first launched in the U.S. in 1989 as a treatment in the management of signs and symptoms of Parkinson’s disease and restless legs syndrome. In February 2003, the FDA issued a safety alert for the drug Permax because of the cardiac valvulopathy that was being observed in patients.
While the warning letter stated [...]
